The Valley Desk

ArticleJournal for immunotherapy of cancerPublished

A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Article
Venue
Journal for immunotherapy of cancer
Published
Subject terms
Animals; Mice, Inbred C57BL; Humans; Mice; Glioblastoma; HMGB1 Protein; Adenosine Triphosphate; Antigens, Neoplasm; Drug Combinations; Immunity; Programmed Cell Death 1 Receptor; Immunogenic Cell Death
PubMed ID
37550054
PubMed Central ID
PMC10407365
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal